NextMeds review
Flat compounded GLP-1 memberships that bundle a care coach and a dietitian, sold behind a countdown timer warning that prices are about to rise.
Pricing last checked on NextMeds's own site .
- Semaglutide
- $79/mo
- Tirzepatide
- $109/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
NextMeds scored on our six published factors. See the methodology.
What we like
- Flat membership price across every dose, shown before intake: $129/mo compounded semaglutide, $149/mo compounded tirzepatide
- One price bundles the medication if prescribed, telehealth consultations, a 1:1 care coach, a US-licensed registered dietitian and free shipping
- Names its compounding pharmacy partners, including Foothills Pharmacy, with a phone number
- Cancel any time with no auto-renewal, and a refund and cancellation policy is linked
- Free online assessment before any payment; no insurance required and FSA eligible
The caveats
- Compounded semaglutide and tirzepatide are not FDA-reviewed or approved, a different regulatory tier from Wegovy or Zepbound
- Urgency marketing: a countdown timer, an 'offer ends August 5th' banner and a 'price increases' warning, yet the standing tirzepatide price actually fell from $179 to $149 over the past fortnight
- Claims LegitScript approval but links only a generic directory search and a self-hosted image, with no verifiable seal ID
- Describes itself as a technology platform coordinating care rather than the medical provider; no clinicians or medical director are named
- Compounded injectables only. No brand-name option and no oral route
- The advertised from $79/mo, 12-mo prepaid is not the month-to-month rate for semaglutide
- The advertised from $125/mo, 12-mo prepaid is not the month-to-month rate for tirzepatide
The verdict
Best for: People who want human support built into the monthly price rather than bought separately or not at all. Flat compounded GLP-1 memberships that bundle a care coach and a dietitian, sold behind a countdown timer warning that prices are about to rise.
Ranked #75 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Fitish at #74, 76/100 above and Claya at #76, 75/100 below, with the Dr. Gillis' Wellness Center ruling the next one down.
Weighing it against something else? Every provider we would put in front of NextMeds is ranked on price honesty, prescriber access and cancellation terms.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs NextMeds goes to CoreAge Rx, 94/100 to 75/100.
Compare with other providers
The closest rulings to NextMeds by Verdict Score — the realistic shortlist if you are weighing this one up.
- #83Rebody Health— Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front.75/100
- #84Revel RX— Revel RX is a Michigan-based telehealth weight-loss platform offering compounded semaglutide at $89/month and compounded tirzepatide at $155/month — flat-rate at every dose tier.75/100
- #85TeleCareSpot— TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month…75/100
- #86Vytora Health— One of the few telehealth platforms publishing both compounded and brand-name prices with named pharmacies, though its own tirzepatide price contradicts itself between card and FAQ.74/100
- #87RX Bella— Four programs priced from a floor on the homepage, a hero quoting the cheapest of them, and treatment pages that carry no price at all.74/100
- #88Prime Doctor RX— The whole ladder is public and the asterisk tells the truth — but the billing cycle is 28 days and every price is labeled "/mo" anyway.74/100
Pricing, states and verification reflect NextMeds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on NextMeds's site. Not medical advice; see our disclosure.